drugset / Trial / NCT03321461

TMTP1-ICG Mapping in Colposcopy-directed Biopsy

NCT03321461 ↗

Phase 1 Unknown 40 enrolled Huazhong University of Science and Technology
RandomizedParallel-groupOpen-labelDiagnostic

Summary

Investigators aimed to determine the validity of the novel tumor targeted fluorescent TMTP1-ICG to increased accuracy of colposcopy-directed biopsy.

Timeline

Start
2017-11-01
Primary completion
2020-08-31
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator ICG Unknown 1 mg/ml Topical
Subject TMTP1 Diagnostic / imaging agent 1 mg/ml Topical